Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

Author: Espinosa E.   Morales S.   Borrega P.   Casas A.   Madroñal C.   Machengs I.   Illarramendi J.   Lizón J.   Moreno J.   Belón J.   Janáriz J.   Puente M.   Checa T.   Mel J.   González Barón M.  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.54, Iss.6, 2004-12, pp. : 546-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content